section name header

Y-Site Injection Compatibility (1:1 Mixture)

Cefiderocol sulfate tosylate

(Mfr: SHI)(Conc: 20 mg/mLc)

I

Tobramycin sulfate

(Mfr: FRK)(Conc: 10 mg/mL)

Remarks:

Results of subvisual tests indicate the presence of white particles

Ref:

3662,3670